United Therapeutics ROE - Return on Equity 2010-2024 | UTHR

United Therapeutics return on equity for the quarter ending September 30, 2024 was 19.22.

  • United Therapeutics average return on equity for 2023 was 16.96, a 2.73% increase from 2022.
  • United Therapeutics average return on equity for 2022 was 16.51, a 27.79% increase from 2021.
  • United Therapeutics average return on equity for 2021 was 12.92, a 21.46% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

United Therapeutics ROE - Return on Equity 2010-2024 | UTHR

  • United Therapeutics average return on equity for 2023 was 16.96, a 2.73% increase from 2022.
  • United Therapeutics average return on equity for 2022 was 16.51, a 27.79% increase from 2021.
  • United Therapeutics average return on equity for 2021 was 12.92, a 21.46% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.